Diabetic Neuropathies
📧 Sign up to get email alerts when something new happens for Diabetic Neuropathies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Integrated Oral Care Intervention for Xerostomia in Diabetes Patients [NA]
This clinical trial update indicates that an integrated oral care intervention for xerostomia in diabetes patients is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy [Phase 3]
Phase 3 clinical trial update assessing the efficacy and tolerability of AP707 in chronic pain due to diabetic polyneuropathy.
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: Cytoflavin in the Treatment of Patients With Diabetic Polyneuropathy [Phase 3]
Phase 3 trial update on Cytoflavin for diabetic polyneuropathy has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Botulinum Toxin Type A in Diabetic Peripheral Neuropathy [Phase 4]
Phase 4 clinical trial update evaluating botulinum toxin type A in diabetic neuropathies has completed.
-
CLINICAL_TRIALS trial_result · 2021-12-07Clinical Trial Update: Enhancing Diabetic Foot Education by Viewing Personal Plantar Pressures [NA]
Clinical trial completed evaluating whether enhancing diabetic foot education by viewing personal plantar pressures impacts outcomes in diab…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: Development and Testing of a New Generation of Diabetic Footwear [NA]
A completed clinical trial on a new generation of diabetic footwear with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Study of DA-9801 to Treat Diabetic Neuropathic Pain [Phase 2]
Phase 2 clinical trial update for DA-9801 in diabetic neuropathic pain has completed.
-
EMA withdrawal · 2013-01-17EMA Withdrawn: Duloxetine Boehringer Ingelheim (duloxetine) — Boehringer Ingelheim International GmbH
Duloxetine (Boehringer Ingelheim) product withdrawn from the market.
-
CLINICAL_TRIALS trial_result · 2009-03-13Clinical Trial Update: Pregabalin Peripheral Neuropathic Pain Study [Phase 3]
Phase 3 clinical trial update for pregabalin in peripheral neuropathic pain completed; results posted in 2009.
-
CLINICAL_TRIALS research · 2006-07-04Clinical Trial Update: Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy [Phase 4]
Phase 4 trial update on Bi-Axial Rotating Magnetic Field Therapy for refractory neuropathic foot pain secondary to diabetic peripheral neuro…